Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

A model-based evaluation on the effectiveness of social distancing in COVID

Researchers utilize a mathematical model-based analysis to assess how social distancing measures contained the COVID-19 pandemic and reduced mortality.

13 Dec 2021

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

In a recent observational study, scientists have described the characteristics of VBIs in fully vaccinated individuals in France.

13 Dec 2021

New England research on population immunity and SARS-CoV-2

A new study discusses a model-based reconstruction of SARS-CoV-2 attack rate and population-immunity curves for three New England states.

13 Dec 2021

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Scientists have recently reported the efficacy of carrageenan against both the SARS-CoV-2 original strain as well as the Alpha, Beta, Gamma, and Delta VOCs.

13 Dec 2021

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

Researchers estimate vaccine efficacy over a period post-vaccination using quantitative antibody assay on finger-prick blood samples.

13 Dec 2021

Surgery rates in U.S. hospitals bounced back to normal after initial COVID-19 shutdown

Stanford Medicine researchers found that after the March 2020 COVID-19 shutdown, nonurgent surgery rates dropped, but within months they bounced back and remained at pre-pandemic levels, even as coronavirus infections peaked during the fall and winter of 2020.

13 Dec 2021

New technology could help determine COVID-19 patients at risk for micro thrombosis-related issues

Physicians treating coronavirus infections have a new diagnostic that could help identify patients at risk of organ failure.

13 Dec 2021

New copper surface could help fight antibiotic-resistant superbugs

A new copper surface that kills bacteria more than 100 times faster and more effectively than standard copper could help combat the growing threat of antibiotic-resistant superbugs.

13 Dec 2021

Glycans strengthen interaction between viral spike proteins and ACE2 receptors on host cells

A new study shows that the ACE2 and RBD of coronavirus spike fragments have different binding strengths and dissociation rates when they are glycosylated and non-glycosylated.

13 Dec 2021

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

A new study provides some possible explanations to the mechanisms by which antiviral activity is exerted by blue LED light and indicated that the alteration of the SARS-CoV-2 spike protein requires the presence of photosensitizers.

13 Dec 2021

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

A review assessed the impact of "hot" vs. "cold" immune/tumor environments (and associated therapies) on susceptibility and disease course in subjects with these two types of tumors and infected with SARS-CoV-2 to decipher the mechanisms that drive these adverse outcomes in COVID-19 infected cancer patients.

13 Dec 2021

SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

13 Dec 2021

What are the implications of orangutan translocation risks in the COVID-19 era?

Can orangutan translocation pose infectious disease transmission and species conservation threats?

13 Dec 2021

Third dose of SARS-CoV-2 vaccine increases protection against omicron variant

A new study examines the variation in vaccine effectiveness against virus variants using estimated reductions in neutralizing antibody levels from published studies.

13 Dec 2021

COVID-19 in association with pre-existing mental and physical health issues

The present study attempts to identify the factors that increase the risk of COVID-19 infection or confer protection against COVID-19 in a study population above 55 years of age known to experience higher morbidity and risk of mortality from COVID-19.

13 Dec 2021